Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries.Friday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Meeting the 2030 End TB goals in the wake of COVID-19: a modelling study of countries in the USAID TB portfolio.Friday, August 9, 2024Availability, Epidemiological impactRead More
Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccineFriday, August 9, 2024Availability, Epidemiological impactRead More
